Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talazoparib and the WEE1 inhibitor adavosertib results in enhanced anti-cancer effects.
from Top Health News -- ScienceDaily https://ift.tt/3fgDUXo
via IFTTT
No comments:
Post a Comment